These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 5115582)

  • 21. Short-term effects of metformin in type 2 diabetes.
    Eriksson A; Attvall S; Bonnier M; Eriksson JW; Rosander B; Karlsson FA
    Diabetes Obes Metab; 2007 May; 9(3):330-6. PubMed ID: 17391159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of normoglycemic activity of endovenous and oral metformin in diabetics].
    Polosa P; Motta L
    Diabete; 1969; 17(1):33-7. PubMed ID: 5791573
    [No Abstract]   [Full Text] [Related]  

  • 23. [Results of oral Diabomet therapy of diabetes mellitus].
    Ipbüker A; Erkurt R
    Turk Tip Cemiy Mecm; 1970; 36(8):287-95. PubMed ID: 5514250
    [No Abstract]   [Full Text] [Related]  

  • 24. Examination of metformin hydrochloride in a continuous dissolution/HDM system.
    Fliszar KA; Foster N
    Int J Pharm; 2008 Mar; 351(1-2):127-32. PubMed ID: 17996409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A crystal clear solution for insulin delivery.
    Merkle HP; Jen A
    Nat Biotechnol; 2002 Aug; 20(8):789-90. PubMed ID: 12148005
    [No Abstract]   [Full Text] [Related]  

  • 26. [Value of an oral hypoglycemic medication combining a sulfonamide with a biguanide Diabiphage (chlorpropamide, Metformin)].
    Plauchu M; Kressmann J; de Montgolfier R; Wittlin R
    Lyon Med; 1971 Apr; 225(8):763-5. PubMed ID: 5577912
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pharmacodynamic and therapeutic study of dimethylbiguanide].
    Rodriguez M; Ruiz M; Puchulu FE; Matianich A
    Prensa Med Argent; 1971 Mar; 58(2):105-9. PubMed ID: 5091406
    [No Abstract]   [Full Text] [Related]  

  • 28. [Controversial aspects regarding metformin in type 2 diabetic patient: reduction of late complications in early, single drug administration; increased risk of death in later administration in combination with sulfonylurea compounds].
    Ritzmann P
    Praxis (Bern 1994); 1999 Aug; 88(33):1330-1. PubMed ID: 10483287
    [No Abstract]   [Full Text] [Related]  

  • 29. [Monitoring of blood sugar levels during insulin treatment of diabetes mellitus].
    Chen JW
    Zhonghua Yi Xue Za Zhi; 1984 Mar; 64(3):184-6. PubMed ID: 6432274
    [No Abstract]   [Full Text] [Related]  

  • 30. [A clinical case of development of lactic acid acidosis in a diabetic patient taking metformin].
    Cesur M; Cekmen N; Cetinbas RR; Badalov P; Erdemli O
    Anesteziol Reanimatol; 2006; (2):65-7. PubMed ID: 16758949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experience in the treatment of diabetes mellitus with delayed-action insulin preparations].
    Piasetskiĭ NR; Tirkina TN; Danilova NS
    Klin Med (Mosk); 1967 May; 45(5):22-8. PubMed ID: 5607519
    [No Abstract]   [Full Text] [Related]  

  • 32. [The anti-atherosclerotic effect of metformin in the initial phases of diabetes mellitus in adults].
    Baraldi B; Maestri G; Cusimano A; Valenti C; Tiraboschi L; Cocuzza E; Angeli G
    Clin Ter; 1980 Mar; 92(6):657-69. PubMed ID: 7006885
    [No Abstract]   [Full Text] [Related]  

  • 33. [Double aim in the treatment of diabetes in obese patients: glycemia equilibration, lipid constant normalization. Trial of delayed-action N,N-dimethyl-biguanide].
    Félix H; Freyria J
    Therapeutique; 1970 Jan; 46(1):61-6. PubMed ID: 5444071
    [No Abstract]   [Full Text] [Related]  

  • 34. Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure.
    Kokić S; Buković D; Radman M; Capkun V; Gabrić N; Lesko V; Karelović D; Stancerić T
    Coll Antropol; 2003 Jun; 27(1):181-7. PubMed ID: 12974145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of metformin plus roziglitazone compared with metformin alone on glycaemic control in well-controlled Type 2 diabetes.
    Stewart MW; Cirkel DT; Furuseth K; Donaldson J; Biswas N; Starkie MG; Phenekos C; Hamann A
    Diabet Med; 2006 Oct; 23(10):1069-78. PubMed ID: 16978370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population exposure-response modeling of metformin in patients with type 2 diabetes mellitus.
    Hong Y; Rohatagi S; Habtemariam B; Walker JR; Schwartz SL; Mager DE
    J Clin Pharmacol; 2008 Jun; 48(6):696-707. PubMed ID: 18372428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin-associated lactic acidosis treated with continuous renal replacement therapy.
    Alivanis P; Giannikouris I; Paliuras C; Arvanitis A; Volanaki M; Zervos A
    Clin Ther; 2006 Mar; 28(3):396-400. PubMed ID: 16750454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin in breast cancer: time for action.
    Goodwin PJ; Ligibel JA; Stambolic V
    J Clin Oncol; 2009 Jul; 27(20):3271-3. PubMed ID: 19487373
    [No Abstract]   [Full Text] [Related]  

  • 39. Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study.
    Blonde L; Dailey GE; Jabbour SA; Reasner CA; Mills DJ
    Curr Med Res Opin; 2004 Apr; 20(4):565-72. PubMed ID: 15119994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The blood sugar depressing action of cyclophosphamide in diabetics].
    Krüger HU
    Med Klin; 1966 Sep; 61(37):1462-3. PubMed ID: 5992109
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.